FibroGen, Inc.FGENNASDAQ
LOADING
|||
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
14 analysts·Moderate coverage
36%
Rating Distribution
Strong Buy
00%
Buy
536%
Hold
750%
Sell
214%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 209% higher.
Bear Case
$28.00
+209%
Consensus
$28.00
+209%
Bull Case
$28.00
+209%
Price Range14 analysts
Low
Consensus
High
$28.00
$28.00
Current Target
Current Price
$9.07
Upside to Target
$18.93
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.